share_log

Novavax | 4: Statement of changes in beneficial ownership of securities-Director King Rachel K.

SEC announcement ·  Jun 15 04:30
Summary by Futu AI
Rachel K. King, associated with Novavax Inc [NVAX], completed a transaction on June 12, 2024, acquiring 6,670 shares of common stock at no cost. This transaction was classified as an exercise or conversion of derivative security, under the transaction code 'M'. Following this acquisition, King's direct holdings in Novavax common stock increased to a total of 18,920 shares. The transaction has been marked as completed.
Rachel K. King, associated with Novavax Inc [NVAX], completed a transaction on June 12, 2024, acquiring 6,670 shares of common stock at no cost. This transaction was classified as an exercise or conversion of derivative security, under the transaction code 'M'. Following this acquisition, King's direct holdings in Novavax common stock increased to a total of 18,920 shares. The transaction has been marked as completed.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.